# 1. Financial Performance ## A. Key Figures * **Revenue (Q1 FY'26):** **₹960 Cr** consolidated (+YoY growth) · **₹947 Cr** previous quarter * **EBITDA Margin:** **>10%** (Q1 FY'26) vs. 2% prior year · **₹96 Cr** Operating EBITDA (+75% YoY) * Gross Margin: 25% (Q1 FY'26) vs. 15.5% prior year · 24% gross material margin * **PBT:** **₹67.1 Cr** (+128% YoY), **7% margin** · **PAT:** **₹50 Cr** (+145% YoY), **5% margin** * **Net Debt:** **₹314 Cr** (as of 30-Jun-25) · **Gross Debt:** ₹780 Cr · **Treasury Balance:** ₹467 Cr ## B. Revenue Growth * **Sustained Momentum:** Revenue growth over two years reflects **strong double-digit CAGR**, underpinned by robust demand in Auto and Industrial segments. * **Full-Year Outlook:** On track to achieve **₹4,800–5,000 Cr** annual revenue, with Q1 typically contributing **20–22%** of full-year sales. * **Strategic Validation:** Recent performance confirms effectiveness of multi-year strategy, with **PLI scheme benefits** expected to further boost top-line and margins. ## C. Profit Margins * **Sharp Margin Expansion:** Significant year-on-year improvement in EBITDA, gross, and PAT margins driven by **healthier business mix** and **operational efficiencies**. * **Structural Levers:** Gross margin trajectory supported by **increasing procurement scale**, enabling cost optimization; segmental margins show **marginal incremental gains** across key verticals. * **ROCE Improvement Path:** Adjusted ROCE at **5%**, with expectations for further uplift as profitability scales and capital efficiency improves. ## D. Balance Sheet * **Working Capital Stability:** Net working capital held at **69 days**, in line with prior quarter; management targeting reduction to **below 65 days** over the year. * **Debt & Liquidity:** Sequential rise in gross debt offset by higher treasury balances; net debt increase of **₹50 Cr** primarily funds working capital needs. * **Self-Funded Growth:** Organic expansion financed through **internal accruals**, maintaining financial flexibility; potential allocation toward **acquisitions or Greenfield projects**. ## E. Cash Flow * **Inventory Turnover Guidance:** Inventory days expected to stabilize **between 60–65 days** in coming quarters, aided by improved execution and order ramp-up dynamics. * **Capital Independence:** No plans for external funding for organic growth, supported by **strong internal cash generation** and working capital optimization. --- # 2. Order Book & Demand ## A. Key Figures * **Revenue Mix:** **24%** automotive (+800 bps) · **30%** industrial (+1100 bps) · **34%** consumer (–1900 bps) · **7%** healthcare (+200 bps) * Order Book (June '25): ₹5,400–5,500 Cr * **Order Book Mix:** **35%–40%** auto · **25%–27%** industrial · **25%–27%** consumer · **6%–8%** healthcare ## B. Segment Mix * **Strategic Mix Shift:** Deliberate pivot toward high-margin businesses evident in rising auto and industrial shares, with consumer segment downweighted as planned. * **Forward-Looking Exposure:** Auto now represents the largest segment in the order book, signaling **accelerating growth momentum** ahead despite current revenue lag. * **Diversification & Resilience:** Industrial and healthcare segments show sustained traction, while muted IT and Railways exposure expected to recover. --- # 3. Capacity & Utilization ## A. Key Figures * **Capacity Utilization:** 65–70% projected for full year (including Pune, Bawal, Chennai expansions) * **Fixed Asset Turnover:** **5x** expected at 65–70% utilization · **6x to 5x+** potential at full capacity * PCB Plant Capacity: 1.5 to 2 million sqm/year (multi- and single-layer) * **PCB Market Context:** **90% of India’s $5B PCB market imported** · **30% of domestic output by single player** ## B. Plant Utilization * **Expansion on Track:** Bangalore greenfield plant on schedule for end-2024 to early-2025 commissioning, supporting future volume absorption. * **Current Underutilization:** Current overall utilization below 50%, with new facilities at ~40%, but expected to rise with operational maturity and demand ramp. * **Production Initiation:** Dyna laptop manufacturing commenced in August, marking early-stage output from new capacity. ## C. Brownfield Expansion * **Execution Timeline:** Project launch expected by end of Q2 FY26 (September 2025), pending state government approvals and incentives. * **Preparatory Readiness:** Blueprint and backend work to be completed within ~45 days post-approval to prevent delays; land identified in multiple states. * **Organizational Buildout:** Ongoing investments in leadership and process improvements over the past 18–24 months to support scaled operations. ## D. PCB JV Timeline * **Targeted Ramp-Up:** Trial production for PCB JV expected in Q3 FY27 (Oct–Dec 2026), with commercial launch in Q4 FY27 or Q1 FY28, subject to PLI approval timing. * **Full-Scale Output Goal:** Full production targeted for Q4 FY27 (Jan–Mar 2027), aiming for a full year of output in FY27–28 if approvals come by September 2026. * **Strategic Advantage:** JV backed by a **Korean technology partner with 50+ years of expertise**, providing access to proven process control and potential customer pipelines in India. * **Asset Efficiency:** PCB plant expected to achieve **1x asset turnover** at full utilization, reflecting capital intensity of the business. --- # 4. Product & Segment Performance ## A. Key Figures * **Smart Metering Revenue:** **₹55–60 Cr** Q1 FY26 · **₹250–300 Cr** expected full-year FY26 * **Railways Revenue:** **₹20–21 Cr** Q1 FY26 · **₹80–100 Cr** expected full-year FY26 * **ODM Contribution:** **~2%** of total business (current quarter) * **PCB EBITDA Margin Target:** **15%–18%** (JV goal, vs. industry 12%–15%) ## B. Consumer Recalibration * **Strategic Shift Executed:** Successful recalibration over past four quarters positions company for growth, with platform now leveraged for scaling. * **Selective Exposure:** Consumer segment to be reduced to **30% of annual revenue**, driven by **poor ROI in low-margin, high-volume** products, not demand weakness. * **Growth in Quality, Not Just Volume:** Focus shifting to **margin-accretive ODM** within consumer, while expanding large-format box build and adding new customers. * **Balanced Portfolio Push:** Deliberate rebalancing to protect investments in **industrial, automotive, med tech, and defense**, despite strong growth in low-margin consumer. ## C. IT & Railways * **IT Visibility Intact:** Q1 softness in IT segment offset by **full-year FY26 guidance reaffirmed**, with potential upside from **motherboard manufacturing resumption** (PLI incentive eligibility). * **Railways on Track:** Q1 revenue in line with expectations; **orders in hand support full-year target** of ₹80–100 Cr. * **Telecom Catalyst Ahead:** **Large antenna projects** set to ramp from **September onwards**, expected to drive near-term growth. ## D. Med Tech & Defense * **High-Margin PCB Play:** JV targeting **15%–18% EBITDA margins** via yield efficiency and advanced tech, above standard 12%–15%. * **Defense: Strategic, Not Tactical:** Pursuing **integrated solutions** (e.g., communication, radar, jamming systems) over basic EMS, aiming for **stickier, higher-value contracts**. * **Defense Model Divergence:** Evaluating dual path—**vanilla EMS partner** for global OEMs vs. **solution integrator** for Indian defense agencies—after **eight quarters of serious review**. * **Lumpy but Strategic Revenue:** Defense expected to be **tender-driven with irregular patterns**, requiring patience but aligning with **Made in India** and long-term diversification goals. * **Backward Integration Explored:** Assessing expansion beyond PCBs into **mechanical and non-passive components**, though currently **small in scope**. --- # 5. Export & Geography Mix ## A. Key Figures * **Exports:** **232 units** Q1 FY'26 (+29% YoY) --- # 6. Risks & Trade Factors ## A. Key Figures * **PLI Incentive (Q):** **₹4–6 Cr** estimated ## B. U.S. Tariff Uncertainty * **Export Orders on Hold:** Tariff uncertainty is currently restraining large export orders, with resolution expected by September, potentially triggering aggressive customer restocking from India. * **Cost Pass-Through Dynamics:** Bulk of the **26% tariff** burden likely to be passed to end consumers due to industry-wide impact, though residual costs will depend on supplier-customer negotiations. * **Strategic Opportunity:** Management views the tariff environment as a catalyst for India—and Syrma SGS specifically—to gain share in global electronics manufacturing. * **Motherboard Expansion Pending:** Local motherboard production not viable on domestic volumes alone; export-driven scale depends on clarity from U.S. tariff resolution. ## C. PLI Approval Delays * **PLI Decision Imminent:** Applications to be reviewed in August, with approval expected by August or September; JV agreement already signed and submission completed by 31st July deadline. * **Technology Edge Secured:** Partnership with a strong technology player in place, critical for yield management in chemical-intensive PCB manufacturing. * **Incentive Visibility:** Quarterly PLI benefit estimated at **₹4–6 Cr**, supporting margin structure upon approval. * **Scale Constraints:** PLI scheme imposes limits on low-margin consumer-related operations, capping allowable business volume in that segment. ## D. Input Cost Volatility * **Input Quality Critical:** Stable, high-quality chemicals and substrates are essential for consistent PCB output, more so than machinery, which remains rugged and reliable post-setup. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Guidance:** **30%–35%** growth expected for the year · **25%–30%** also cited with implied **~40% growth in non-Consumer segments** * EBITDA Margin Guidance: 8.5%–9% for the year, revised from prior ~8% · 18%–20% targeted at mature PCB plant * **CAPEX:** **₹35 Cr** spent in Q1 · **$91 Mn** for Phase-1 PCB project over 3–5 years · **Full-year EMS CAPEX guidance < ₹100 Cr** * **PLI Benefit:** Expected to contribute **5%–7% of revenue (~₹80–100 Cr)** * **Funding:** **$91 Mn PCB CAPEX** to be partially offset by **40%–60% subsidies**; internal accruals of **>₹400 Cr** on hand ## B. Revenue Targets * **Confidence in Full-Year Delivery:** Management reaffirmed guidance, citing strong order book, IT growth, rear-loaded Med Tech, and export momentum. * **Aggressive Catch-Up Required:** Achieving targets necessitates **robust quarter-on-quarter growth (~38%–40%)** in remaining three quarters. * **Execution Pathway:** Must generate **₹1,300 Cr average per quarter** (~₹3,900–4,100 Cr total) in next nine months, supported by Dyna and MSI partnerships. * **Seasonality Tailwinds:** H2 expected to contribute **50%–55%** of annual revenue, aligning with historical rear-loaded performance. ## C. Margin Forecast * **Margin Rebound in View:** EBITDA margin outlook improved to 5%–9% on Q1 performance and execution confidence, with **further expansion expected across verticals**. * **PLI to Boost Margins:** Excluding PCB CAPEX, **PLI benefits** will contribute meaningfully to profitability, adding **5%–7% to revenue**. * **Long-Term Margin Upside:** PCB plant, once ramped, targets **18%–20% EBITDA margins** and **~20% ROCE**, signaling high-return potential. ## D. CAPEX Plan * **Phased, Subsidized Investment:** PCB Phase-1 CAPEX of **$91 Mn** will be deployed modularly over 3–5 years, with **$30–35 Mn** in first 12–18 months. * **Significant Subsidy Support:** **35%–60%** of PCB CAPEX eligible for state and central incentives, including GST refunds and employment benefits; **40%–50% reimbursement expected**. * **Self-Funded Near-Term Plan:** Current **<₹100 Cr annual CAPEX** in EMS is manageable via internal accruals, though **capacity constraints may emerge in FY '27**. * **Contingent Fundraise Possible:** A **QIP of ~₹1,000 Cr** may be pursued only if large acquisition or incremental CAPEX arises; PCB project seen as **bridge financing need**.